Harvard licenses kidney engineering technology to Trestle…

Powerful combination of 3D bioprinting and stem cell-based tissue engineering could enable new approaches to treating chronic kidney disease

Related Keywords

Boston ,Massachusetts ,United States ,Ryuji Morizane ,Ben Shepherd ,Joseph Bonventre ,Jennifer Lewis ,Ruji Morizane ,Alice Chen ,Donald Ingber ,Engineering In Medicine Division ,Harvard Stem Cell Institute ,Harvard Medical School ,Wyss Institute Organ Engineering Initiative ,Wyss Institute ,Division Of Renal Medicine ,Harvard Office Of Technology Development ,Sciences Engineering Accelerator ,Lewis Lab ,Biologically Inspired Engineering ,Harvard University ,Harvard John ,Applied Sciences ,Technology Development ,Wyss Core Faculty ,Organ Engineering Initiative ,Wyss Professor ,Affiliated Faculty ,Renal Medicine ,Founding Chief ,Medicine Division ,Assistant Professor ,Massachusetts General Hospital ,Visiting Scholar ,Engineering Accelerator ,Nature Methods ,Wyss Founding Director Donald Ingber ,Judah Folkman Professor ,Vascular Biologyat ,Boston Children ,Startups ,Ioengineering ,Tissue Engineering ,Stem Cells ,